According to CNN’s Dr. Sanjay Gupta, there are about 20 different medications that are currently in trials to treat COVID-19.
One of those is the antiviral drug, Favipiravir or Avigan. Japan has used it to treat the flu, Pharmaceutical Technology reported that last month. As an experimental treatment for COVID-19 infections, the drug was approved. So far, reports suggest it has a high degree of safety and is clearly effective in treatment. China’s science and technology ministry made the statement. The Guardian reported it. The drug works by preventing certain viruses from replicating. Also, it seemed to shorten the duration of the virus. In addition, it improved lung conditions (as seen in X-rays) in tested patients.
Losartan is a generic blood-pressure medication that some scientists are hoping could help patients with COVID-19. The University of Minnesota has launched two clinical trials using the inexpensive, generic drug. The first would evaluate whether losartan can prevent multi-organ failure in those hospitalized with COVID-19 pneumonia. The second would evaluate if the drug can prevent hospitalizations in the first place, Reuters reported.
Bruce Aylward of the World Health Organization said last month, “There’s only one drug right now that we think may have real efficacy, and that’s remdesivir,” as reported by STAT. George Thompson, an infectious disease specialist at UC Davis Medical Center who treated an early, severe case of COVID-19, told Science magazine that their patient got better after getting the drug, about 36 hours after diagnosis. The doctors initially thought the patient would die, Thompson said. The first COVID-19 patient diagnosed in the United States—a young man in Snohomish county in Washington—was given remdesivir when his condition worsened; he improved the next day, according to a case report in The New England Journal of Medicine (NEJM).